Featured Articles
- 
                    Rare Disease R&D: Continued Growth Amid Challenges
                        3/21/2025
                    The market for rare disease treatments continues to grow but it is not without its challenges, including small patient populations and a lack of existing research. 
- 
                    Outlook 2025: Key Trends & Insights
                        2/19/2025
                    Dive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies. 
- 
                    Answer Your Critical Clinical Questions — Faster Than Ever
                        2/19/2025
                    Pressing clinical planning questions to ask about feasibility, investigator selection, patient enrollment, clinical trial disclosure, and more. 
- 
                    Antibody-Drug Conjugates: 'Magic Bullets' Become Reality
                        2/19/2025
                    Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including antibody-drug conjugates (ADCs). Learn more about ADCs’ makeup, mechanisms, and the development landscape. 
- 
                    The Scoop On The SCOPE Summit
                        2/19/2025
                    From industry partnerships to patient recruitment to proprietary data, SCOPE 2025 was packed with informational sessions. 
- 
                    Merits Of A Multifaceted Approach To Clinical Trial Recruitment
                        1/27/2025
                    The best way to address clinical trial recruitment challenges is with a multifaceted approach that goes beyond traditional channels and ways of thinking. 
- 
                    Use Case: A Patient-Centric Approach To Site Selection
                        1/27/2025
                    Discover how Citeline’s robust datasets, combined with real-world data, inform intelligent site and investigator selection for a rare, autoimmune disease. 
- 
                    What's The Current & Future Impact Of AI On Pharmaceutical R&D
                        1/17/2025
                    Explore the results of a survey where senior decision-makers in the life sciences industry provided their perceptions and expectations of AI to understand current AI adoption trends. 
- 
                    What Does 2025 Hold For Pharma?
                        1/17/2025
                    Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments. 
- 
                    Top 10 Tips For Diversity Plans
                        12/13/2024
                    Explore the updated guidance from the FDA to enhance diversity in clinical trials, including ten times to developing a comprehensive Diversity Action Plans. 
